Immunotherapy Before Transplantation for Skin Cancer Prevention in Organ Transplant Recipients

NCT04329221 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped The study was withdrawn due to lack of financial support.

Conditions

Cutaneous Squamous Cell Carcinoma
Actinic Keratoses
Skin Cancer
Organ Transplant Recipients
Immunotherapy

Interventions

DRUG: Calcipotriol Only Product in Cutaneous Dose Form
DRUG: Vaseline
DRUG: Topical 5FU

Sponsor

Massachusetts General Hospital

Collaborators

[object Object]